DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma

Clinical trial NCT04334759 · COMPLETED

Trial details

NCT number: NCT04334759
Sponsor: PrECOG, LLC.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Mesothelioma Pleural Mesothelioma Malignant Pleural Mesothelioma

Start date: 2021-02-18
Primary completion: 2025-06-20
Enrollment: 214

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.